GI Oncology
News
Esophageal Cancer Survival Benefit Linked to Lymphadenectomy
News
FDA Warns of QT Prolongation with Ondansetron Dose
News
Adjuvant Cetuximab Fails to Boost FOLFOX in Stage III Colon Cancer
News
Vismodegib Blocks Hedgehog-Expressing Pancreatic Cancer
Major Finding: Initial treatment with vismodegib followed by standard chemotherapy with gemcitabine yielded a 3-month progression-free survival...
News
Metformin May Reduce Liver Cancer Risk
Major Finding: Metformin use reduced the risk of intrahepatic cholangiocarcinoma by nearly 60%, compared with nonmetformin use.
News
Regorafenib Delays Progression of Refractory Metastatic GIST
Major Finding: Median progression-free survival was 4.8 months with regorafenib vs.
News
H. Pylori Infection, Colonic Neoplasms Linked
Major Finding: The prevalence of H.
News
Screening Colonoscopy Can Benefit Selected Elderly People
Major Finding: Colonoscopy detected carcinoma in 9% of people 76-85 years old who never previously underwent colonoscopy.Data Source: Data came...
Conference Coverage
Bevacizumab Beyond Progression Extends Survival in Metastatic CRC
News
Lymphadenectomy Underused in GI Cancer Surgery
Major Finding: By 2009, the percentage of patients with adequate lymphadenectomy during surgery for gastrointestinal cancer was 43% for esophageal...